Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way.
暂无分享,去创建一个
E. Vardar | S. Aktaş | Nuket Eliyatkın | B. Zengel | Evrim Yalçın | Nuket Eliyatkın | Evrim Yalçın | Baha Zengel | Safiye Aktaş | Enver Vardar | N. Eliyatkın
[1] J. Lamovec,et al. Metastatic pattern of infiltrating lobular carcinoma of the breast: An autopsy study , 1991, Journal of surgical oncology.
[2] Umberto Veronesi,et al. Rethinking TNM: breast cancer TNM classification for treatment decision-making and research. , 2006, Breast.
[3] J. Reis-Filho,et al. Breast cancer precursors revisited: molecular features and progression pathways , 2010, Histopathology.
[4] C. Fan,et al. PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer , 2012, Breast Cancer Research and Treatment.
[5] Sunil R Lakhani,et al. Pleomorphic lobular carcinoma of the breast: molecular pathology and clinical impact. , 2009, Future oncology.
[6] I. Ellis,et al. Lobular breast carcinoma and its variants. , 2010, Seminars in diagnostic pathology.
[7] A. Nobel,et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Melissa P. Murray,et al. Is pleomorphic lobular carcinoma really a distinct clinical entity? , 2008, Journal of surgical oncology.
[9] Karen Gelmon,et al. Metastatic behavior of breast cancer subtypes. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] I. Ellis,et al. Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. , 2008, European journal of cancer.
[11] R. Gelber,et al. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] A. Jemal,et al. Global Cancer Statistics , 2011 .
[13] J. Reis-Filho,et al. Histological and molecular types of breast cancer: is there a unifying taxonomy? , 2009, Nature Reviews Clinical Oncology.
[14] Jorge S. Reis-Filho,et al. Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver Agreement , 2011, Journal of the National Cancer Institute.
[15] B. Kreike,et al. Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype‐matched ductal and lobular carcinomas , 2010, The Journal of pathology.
[16] I. Ellis,et al. High Frequency of Coexistence of Columnar Cell Lesions, Lobular Neoplasia, and Low Grade Ductal Carcinoma In Situ With Invasive Tubular Carcinoma and Invasive Lobular Carcinoma , 2007, The American journal of surgical pathology.
[17] N. Weidner,et al. Pleomorphic variant of invasive lobular carcinoma of the breast. , 1992, Human pathology.
[18] L. Pusztai,et al. Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy , 2006, Nature Clinical Practice Oncology.
[19] J. Reis-Filho,et al. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet? , 2009, International journal of surgical pathology.
[20] John Quackenbush,et al. A three-gene model to robustly identify breast cancer molecular subtypes. , 2012, Journal of the National Cancer Institute.
[21] Lajos Pusztai,et al. Molecular classification of breast cancer: limitations and potential. , 2006, The oncologist.
[22] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[23] I. Ellis,et al. Clinical and Biological Significance of E-cadherin Protein Expression in Invasive Lobular Carcinoma of the Breast , 2010, The American journal of surgical pathology.
[24] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[25] V. Eusebi,et al. Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation. , 1992, Human pathology.
[26] P. Ravdin,et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] A. Ashworth,et al. Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas , 2008, The Journal of pathology.
[28] Amy V Kapp,et al. Discovery and validation of breast cancer subtypes , 2006, BMC Genomics.
[29] G. Azabdaftari,et al. Refinement of breast cancer classification by molecular characterization of histological special types , 2009 .
[30] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[31] R. Roylance,et al. Multiple ways of silencing E‐cadherin gene expression in lobular carcinoma of the breast , 2001, International journal of cancer.
[32] A. Nobel,et al. The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.
[33] H Buerger,et al. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes , 1999, The Journal of pathology.
[34] T. Mukohara. Mechanisms of resistance to anti‐human epidermal growth factor receptor 2 agents in breast cancer , 2011, Cancer science.
[35] N. Sneige,et al. Clinical, Histopathologic, and Biologic Features of Pleomorphic Lobular (Ductal-Lobular) Carcinoma In Situ of the Breast: A Report of 24 Cases , 2002, Modern Pathology.
[36] S. Lakhani,et al. Molecular classification of breast cancer: is it time to pack up our microscopes? , 2011, Pathology.
[37] A. Vincent-Salomon,et al. Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma. , 2010, European journal of cancer.
[38] Samuel Leung,et al. Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype , 2008, Clinical Cancer Research.
[39] R. Gelber,et al. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[40] H. Horlings,et al. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck , 2009, Proceedings of the National Academy of Sciences.
[41] K. Camphausen,et al. Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer , 2010, Breast Cancer Research and Treatment.
[42] N. Sneige,et al. Clinical, Histopathologic, and Biologic Features of Pleomorphic Lobular (Ductal-Lobular) Carcinoma In Situ of the Breast: A Report of 24 Cases , 2002 .
[43] C. Singer,et al. Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients , 2010, Clinical Cancer Research.
[44] M. Borst,et al. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. , 1993, Surgery.
[45] J. Baselga,et al. A major role of p95/611-CTF, a carboxy-terminal fragment of HER2, in the down-modulation of the estrogen receptor in HER2-positive breast cancers. , 2010, Cancer research.
[46] P. Sorensen,et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. , 2002, Cancer cell.
[47] Emad A. Rakha,et al. Combinatorial biomarker expression in breast cancer , 2010, Breast Cancer Research and Treatment.
[48] M. Campiglio,et al. HER2 splice variants and their relevance in breast cancer , 2011 .
[49] A. Luini,et al. Lack of prognostic significance of “classic” lobular breast carcinoma: a matched, single institution series , 2009, Breast Cancer Research and Treatment.
[50] S. Singletary,et al. Breast Cancer Staging: Working With the Sixth Edition of the AJCC Cancer Staging Manual , 2006, CA: a cancer journal for clinicians.
[51] B. Kreike,et al. The molecular underpinning of lobular histological growth pattern: a genome‐wide transcriptomic analysis of invasive lobular carcinomas and grade‐ and molecular subtype‐matched invasive ductal carcinomas of no special type , 2010, The Journal of pathology.
[52] S. Lakhani,et al. Aberrant Expression of E-cadherin in Lobular Carcinomas of the Breast , 2008, The American journal of surgical pathology.
[53] S. Schnitt. Will Molecular Classification Replace Traditional Breast Pathology? , 2010, International journal of surgical pathology.
[54] I. Ellis,et al. The Nottingham prognostic index in primary breast cancer , 2005, Breast Cancer Research and Treatment.
[55] Johan Staaf,et al. Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[56] I. Ellis,et al. Columnar Cell Lesions of the Breast: The Missing Link in Breast Cancer Progression?: A Morphological and Molecular Analysis , 2005, The American journal of surgical pathology.
[57] A. Vincent-Salomon,et al. Columnar Cell Lesions of the Breast , 2003, Advances in Anatomic Pathology.
[58] Charles M. Perou,et al. Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer , 2009, Journal of the National Cancer Institute.
[59] Shu Ichihara,et al. Breast cancer prognostic classification in the molecular era: the role of histological grade , 2010, Breast Cancer Research.